Fifth Third Bancorp Bio N Tech Se Transaction History
Fifth Third Bancorp
- $28.3 Billion
- Q2 2025
A detailed history of Fifth Third Bancorp transactions in Bio N Tech Se stock. As of the latest transaction made, Fifth Third Bancorp holds 408 shares of BNTX stock, worth $42,905. This represents 0.0% of its overall portfolio holdings.
Number of Shares
408
Previous 408
-0.0%
Holding current value
$42,905
Previous $37,000
16.22%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BNTX
# of Institutions
320Shares Held
40.9MCall Options Held
1.38MPut Options Held
1.52M-
Baillie Gifford & CO8.04MShares$845 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$445 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$421 Million0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.6MShares$378 Million0.24% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$199 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...